Anzeige
Mehr »
Sonntag, 01.03.2026 - Börsentäglich über 12.000 News
Erste Psilocybin-Behandlungen laufen - warum steht Optimi noch bei Pennystock-Level?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
10:42Payments-ocalypse: Could AI agents kill the credit card?
09:30Anthropic: The $25 billion engine hidden inside Amazon's cloud
02:54AI adoption in fashion is moving faster than the market realizes, UBS says
02:06Potential PayPal-Stripe merger could reshape global payments, says Bernstein
01:06Samsung's golden 'memory era': Why analysts see a trillion-dollar future
SaBlock's 40% headcount cut seen as AI-driven reset, says Bernstein
SaApple seen as 'anti-AI' safe haven, says MoffettNathanson
SaBerkshire's Abel vows to uphold Buffett's 'framework' in first shareholder letter
SaAnthropic cyber launch not an existential risk to sector, Bernstein says
SaGaranti BBVA announces warrant redemption prices
SaNvidia to develop new chip to accelerate AI- report
SaJPMorgan upgrades Coles Group stock rating on valuation gap
SaWilliam R. Keating invests in United States Treasury Bills and VMWare LLC Note
SaJosh Gottheimer makes key trades in Gilead Sciences and Intercontinental Exchange
SaCathie Wood's ARK adds Kratos stock, trims Teradyne
SaFDA approves Ascendis' once-weekly achondroplasia treatment
SaPNM declares $1.145 quarterly preferred stock dividend
SaOpGen rebrands as CapForce, shifts to digital investment banking
SaAvalon GloboCare closes $3.25 million private placement
FrHawaiian Electric FY 2025 slides: profitability returns amid wildfire recovery
FrSITE Centers sells Colorado shopping center for $24.4M
FrFMC Corporation declares 8-cent quarterly dividend
FrSOL Strategies proposes new board slate for March 31 AGM
FrBurcon closes $2.75M tranche of convertible debenture offering
FrXTL Biopharmaceuticals faces Nasdaq delisting notice